PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacoeconomics and Pharma Management, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.\', \'Department of Pharmacoeconomics and Pharma Management, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.\', \'Medical Department, Orchid Pharmed Company, Tehran, Iran.\', \'Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.\', \'Department of Clinical Pharmacy, Faculty of Medicine, Aja University of Medical Sciences, Tehran, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/1744666X.2021.1908128
?:doi
?:hasPublicationType
?:journal
  • Expert review of clinical immunology
is ?:pmid of
?:pmid
?:pmid
  • 33823733
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.097
?:rankingScore_hIndex
  • 38
?:title
  • Efficacy and safety of Tocilizumab in severe and critical COVID-19: A Systematic Review and Meta-Analysis.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33823733>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33823733>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all